關鍵數據
7.160今開
7.260最高
0.00成交量
2.90本益比TTM
49.75本益比動
--股利TTM
0.06%換手率
7.150昨收
6.975最低
0.00成交額
虧損本益比靜
5.84市淨率
0.00%股息率 TTM
42.24%ROA
12.94052週最高
0.10量比
-31.40M淨利潤
12.28M總股本
2.4434每股盈餘TTM
1.07Beta
-16631.70%ROE
4.95052週最低
4.14%振幅
48.63%毛利率
87.80M總市值
13.41回報/風險
4.24%風險率

即將為您帶來更多新聞,敬請期待。 。 。
LENSAR Inc評分
-0.05與上次評分對比預測9.00
財務診斷7.20
技術分析4.33
公司估值9.69
機構認同度5.00
風險評估3.01
分析師評級
強力買入評級
11.000目標均價
+51.72%漲幅空間
LENSAR Inc 最新財報電話會記錄
LENSAR 2026 年第二季法說會:隨經常性銷售成長,營收成長 18%
LENSAR 於 2026 年第二季財報電話會議中詳細說明了 18% 的營收成長、1,370 萬美元的經常性營收、創紀錄的調整後 EBITDA,以及 ALLY 的持續採用。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
LENSAR Inc 簡介
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
行業醫療設備與耗材
公司代碼LNSR
員工數量140
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| North Run Capital, LP | 9.35% |
|---|
| Brandes Investment Partners, L.P. | 7.07% |
|---|
| Curtis (Nicholas T) | 7.06% |
|---|
| BlackRock Institutional Trust Company, N.A. | 4.84% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 27.45% |
|---|
| Individual Investor | 21.79% |
|---|
| Hedge Fund | 11.93% |
|---|
| Investment Advisor/Hedge Fund | 7.97% |
|---|
常見問題
LENSAR Inc(LNSR)的當前股價是多少?
LENSAR Inc(LNSR)的當前股價是 7.15。
LENSAR Inc股票的52週最高點是12.94。
LENSAR Inc股票的52週最低點是4.95。
現在LENSAR Inc(LNSR)的股票是買入、持有還是賣出?
根據分析師評級,LENSAR Inc(LNSR)的總體評級為STRONG BUY,目標價格為11.00。
LENSAR Inc(LNSR)股票的每股收益(EPS TTM)是多少
LENSAR Inc(LNSR)股票的每股收益(EPS TTM)是2.44。